Your browser doesn't support javascript.
loading
The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.
Cada, Michaela; Segbefia, Catherin I; Klaassen, Robert; Fernandez, Conrad V; Yanofsky, Rochelle A; Wu, John; Pastore, Yves; Silva, Mariana; Lipton, Jeffrey H; Brossard, Josee; Michon, Bruno; Abish, Sharon; Steele, MacGregor; Sinha, Roona; Belletrutti, Mark; Breakey, Vicky; Jardine, Lawrence; Goodyear, Lisa; Sung, Lillian; Shago, Mary; Beyene, Joseph; Sharma, Preeti; Zlateska, Bozana; Dror, Yigal.
Afiliación
  • Cada M; Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada.
  • Segbefia CI; Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada.
  • Klaassen R; Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Fernandez CV; IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Yanofsky RA; CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Wu J; British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
  • Pastore Y; Hôpital Ste. Justine, Montréal, Québec, Canada.
  • Silva M; Queen's University, Kingston, Ontario, Canada.
  • Lipton JH; Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Brossard J; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.
  • Michon B; Centre Hospital University Quebec-Pav CHUL, Sainte-Foy, Quebec, Canada.
  • Abish S; Montreal Children's Hospital, Montreal, Québec, Canada.
  • Steele M; Alberta Children's Hospital, Calgary, Alberta, Canada.
  • Sinha R; University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • Belletrutti M; University of Alberta/Health Sciences Centre, Edmonton, Alberta, Canada.
  • Breakey V; McMaster Children's Hospital/McMaster University Health Sciences Centre, Hamilton, Ontario, Canada.
  • Jardine L; Children's Hospital of Western Ontario, London, Ontario, Canada.
  • Goodyear L; Janeway Child Health Centre, St. John's, Newfoundland, Canada.
  • Sung L; The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Shago M; Division of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Beyene J; Program in Population Genomics, Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
  • Sharma P; Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada.
  • Zlateska B; Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada.
  • Dror Y; Marrow Failure and Myelodysplasia Program, Division of Haematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada yigal.dror@sickkids.ca.
Haematologica ; 100(5): 633-42, 2015 May.
Article en En | MEDLINE | ID: mdl-25682607
ABSTRACT
Inherited bone marrow failure syndromes are a group of rare, heterogeneous genetic disorders with a risk of clonal and malignant myeloid transformation including clonal marrow cytogenetic abnormalities, myelodysplastic syndrome and acute myeloid leukemia. The clinical characteristics, risk classification, prognostic factors and outcome of clonal and malignant myeloid transformation associated with inherited bone marrow failure syndromes are largely unknown. The aims of this study were to determine the impact of category, cytopathology and cytogenetics, the three components of the "Category Cytology Cytogenetics" classification of pediatric myelodysplastic syndrome, on the outcome of clonal and malignant myeloid transformation associated with inherited bone marrow failure. We used data from the Canadian Inherited Marrow Failure Registry. Among 327 patients with inherited bone marrow failure syndrome enrolled in the registry, the estimated risk of clonal and malignant myeloid transformation by the age of 18 years was 37%. The risk of clonal and malignant myeloid transformation varied according to the type of inherited bone marrow failure syndrome but was highest in Fanconi anemia. The development of clonal and malignant myeloid transformation significantly affected overall survival. Mortality varied based on cytopathological group. The largest group of patients had refractory cytopenia. Clonal marrow cytogenetic abnormalities were identified in 87% of patients with clonal and malignant myeloid transformation, and different cytogenetic groups had different impacts on disease progression. We conclude that category, cytopathology and cytogenetics in cases of clonal and malignant myeloid transformation associated with inherited bone marrow failure syndromes have an important impact on outcome and that the classification of such cases should incorporate these factors.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Transformación Celular Neoplásica / Aberraciones Cromosómicas / Evolución Clonal / Hemoglobinuria Paroxística Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: America do norte Idioma: En Revista: Haematologica Año: 2015 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Transformación Celular Neoplásica / Aberraciones Cromosómicas / Evolución Clonal / Hemoglobinuria Paroxística Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: America do norte Idioma: En Revista: Haematologica Año: 2015 Tipo del documento: Article País de afiliación: Canadá